Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Clinical Cancer Research
Clinical Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Imaging, Diagnosis, Prognosis

Clinical Implications of Fibroblast Activation Protein in Patients with Colon Cancer

Leonard R. Henry, Hyung-Ok Lee, John S. Lee, Andres Klein-Szanto, Perry Watts, Eric A. Ross, Wen-Tien Chen and Jonathan D. Cheng
Leonard R. Henry
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hyung-Ok Lee
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John S. Lee
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andres Klein-Szanto
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Perry Watts
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eric A. Ross
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wen-Tien Chen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jonathan D. Cheng
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1078-0432.CCR-06-1746 Published March 2007
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Fig. 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 1.

    Representative examples of FAP expression by immunohistochemistry. Semiquantitative analysis of stromal expression of FAP was graded as 0, 1+ (1-10% stromal staining), 2+ (11-50% stromal staining), and 3+ (51-100% stromal staining). Representative examples of the various categories of FAP staining.

  • Fig. 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 2.

    FAP expression in representative HT29 xenografted tumor tissues. A to C, immunohistochemical analysis of FAP expression of different tumor sizes (A, 0.047 g; B, 0.32 g; C, 0.98 g). Arrows, stromal area in the tumor. D, measurement of area and intensity of FAP expression by ACIS. Histogram shows the average percent of FAP expression [% = brown area / brown (FAP staining) + blue (nuclear staining) × 100].

  • Fig. 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 3.

    Kaplan-Meier curve of patients with known metastases. Survival was estimated using Kaplan-Meier methods, which showed greater FAP intensity resulted in worse survival.

Tables

  • Figures
  • Table 1.

    Patient and tumor characteristics

    n (%)
    Total138
    Sex
        Female71 (51)
        Male67 (49)
    Tumor location
        Right62 (45)
        Transverse9 (7)
        Left13 (9)
        Sigmoid37 (27)
        Rectosigmoid17 (12)
    Tumor grade
        Well differentiated7 (5)
        Moderately differentiated110 (80)
        Poorly differentiated20 (15)
    Stage
        I6 (4)
        II52 (38)
        III43 (31)
        IV37 (27)
    Chemotherapy use
        None recorded52 (38)
        Adjuvant56 (41)*
        Metastatic33 (24)*
        Unknown9 (7)
    • ↵* Twelve patients had chemotherapy in both the adjuvant and metastatic setting.

  • Table 2.

    FAP expression in relation to cancer stage

    FAP expressionNo. of specimens (N = 138)FAP semiquantitatively high, n (%)FAP semiquantitatively low, n (%)PFAP intensity high, n (%)FAP intensity low, n (%)P
    Stage
        I65 (83)1 (17)0.014 (67)2 (33)0.009
        II5245 (87)7 (13)37 (71)15 (29)
        III4330 (70)13 (30)29 (67)14 (33)
        IV3721 (57)16 (43)14 (38)23 (62)
    Grade
        Well differentiated75 (71)2 (29)0.754 (57)3 (43)0.94
        Moderately differentiated11079 (72)31 (28)66 (60)44 (40)
        Poorly differentiated2016 (80)4 (20)13 (65)7 (35)
        Unknown11 (100)1 (100)
PreviousNext
Back to top
Clinical Cancer Research: 13 (6)
March 2007
Volume 13, Issue 6
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Clinical Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Clinical Implications of Fibroblast Activation Protein in Patients with Colon Cancer
(Your Name) has forwarded a page to you from Clinical Cancer Research
(Your Name) thought you would be interested in this article in Clinical Cancer Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Clinical Implications of Fibroblast Activation Protein in Patients with Colon Cancer
Leonard R. Henry, Hyung-Ok Lee, John S. Lee, Andres Klein-Szanto, Perry Watts, Eric A. Ross, Wen-Tien Chen and Jonathan D. Cheng
Clin Cancer Res March 15 2007 (13) (6) 1736-1741; DOI: 10.1158/1078-0432.CCR-06-1746

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Clinical Implications of Fibroblast Activation Protein in Patients with Colon Cancer
Leonard R. Henry, Hyung-Ok Lee, John S. Lee, Andres Klein-Szanto, Perry Watts, Eric A. Ross, Wen-Tien Chen and Jonathan D. Cheng
Clin Cancer Res March 15 2007 (13) (6) 1736-1741; DOI: 10.1158/1078-0432.CCR-06-1746
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Background
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • FDOPA PET Survival Predictions for Glioma
  • In vivo Fluorescence Lifetime Imaging for Monitoring the Cancer Treatment
  • Variability in Assessing Response in Metastatic Colorectal Cancer
Show more Imaging, Diagnosis, Prognosis
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • CCR Focus Archive
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Clinical Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Clinical Cancer Research
eISSN: 1557-3265
ISSN: 1078-0432

Advertisement